Home | Welcome to Contract Pharma   
Last Updated Thursday, May 28 2015


ChemDiv Earns Lilly Milestones

Published December 19, 2012
Related Searches: CRO Pharma Supplement Development
ChemDiv, Inc., a drug discovery and development CRO, has received several milestones across three therapeutic areas under its collaboration with Eli Lilly. Financial details were not disclosed.
Alex Kiselyov, Ph.D., president of ChemDiv, said, "Using our integrated drug discovery platforms, a team of chemists and biologists at ChemDiv identified multiple active series to supplement therapeutic programs at Eli Lilly. This is yet another step in our successful collaborative efforts with pharma and biotech partners to identify advanced preclinical drug candidates."

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On